ClinConnect ClinConnect Logo
Search / Trial NCT04639388

Understanding of Psychotic Disorders in Children With 22q11.2DS

Launched by HÔPITAL LE VINATIER · Nov 17, 2020

Trial Information

Current as of August 19, 2025

Recruiting

Keywords

ClinConnect Summary

The clinical trial titled "PremiCeS22" is focused on understanding early signs of psychotic disorders in children who have a condition called 22q11.2 Deletion Syndrome. This syndrome can affect how children develop and may lead to mental health challenges as they grow. The researchers aim to identify warning signals that could indicate the beginning of these disorders, helping to provide better support and treatment options for affected children.

To participate in this study, children must be between 4 and 13 years old and either have a diagnosis of 22q11.2 Deletion Syndrome or no developmental issues at all. They should also be able to speak French. Unfortunately, children with certain intellectual disabilities or those taking specific medications that might affect brain function cannot participate. If eligible, participants will be part of a supportive research environment where their experiences and health will be closely monitored, contributing to a better understanding of how to help children facing these challenges.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Diagnosis of 22q11.2 deletion syndrome or no developmental disease
  • Aged from 4 to 13 years old
  • French language
  • Exclusion Criteria:
  • Diagnosis of intellectual deficiency according to DSM 5 criteria
  • Drug prescribed for somatic condition that could influence cerebral functioning

About Hôpital Le Vinatier

Hôpital Le Vinatier is a leading psychiatric hospital located in France, renowned for its commitment to advancing mental health care through innovative research and clinical trials. With a focus on integrating clinical practice and scientific inquiry, the institution aims to enhance treatment protocols and therapeutic outcomes for individuals with psychiatric disorders. Hôpital Le Vinatier collaborates with multidisciplinary teams of healthcare professionals and researchers to conduct rigorous studies, ensuring the highest standards of ethical practice and patient safety. Its dedication to improving mental health services makes it a pivotal player in the field of psychiatric research.

Locations

Lyon, Rhone Alpes, France

Patients applied

0 patients applied

Trial Officials

Marie-Noëlle BABINET

Principal Investigator

CH LE VINATIER

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials